L. Chen et al.
Phytochemistry 153 (2018) 147–155
and then partitioned with petroleum ether, EtOAc, and n-butanol, re-
spectively. The n-butanol extract (180 g) was dissolved in 10% EtOH-
209 (−1.38), 251 (+0.51) nm. IR (KBr) νmax 3368, 2972, 2927, 2796,
1711, 1631, 1605, 1465, 1440, 1377, 1345, 1311, 1284, 1224, 1182,
−
1
1
13
H
2
O, and subjected to a D101 macroporous resin column using the
stepwise elution of H O-EtOH (90:10, 60:40, 40:60, and 5:95, v/v) to
yield four fractions (Fr.A–Fr.D). Fr.B was separated by silica gel CC
using a gradient of CH Cl -MeOH (90:10-5:95, v/v) to afford five sub-
fractions (Fr.B1–Fr.B5). Fr.B1 was separated by silica gel CC and eluted
with petroleum ether-Me CO-Et N (10:1:0.1–1:1:0.1, v/v/v) to produce
compounds 2 (12 mg) and 3 (17 mg). Fr.B2 was subjected to silica gel
CC with EtOAc-MeOH-Et N (20:1:0.2–1:1:0.2, v/v/v) to give three sub-
fractions, Fr.B2-1–Fr.B2-3. Fr.B2-2 was subjected to ODS CC with
CH CN-H O (2:8, v/v) to produce compounds 1 (14 mg) and 4 (2 mg).
Fr.B4 was applied to silica gel CC and eluted with EtOA-MeOH-Et
1084, 1008, 997, 913, 770 cm
;
H and C NMR data, see Table 4;
H]+ (calcd for
36NO ,
5
2
HR-ESI-MS (m/z): 430.2601 [M
+
C
25
H
430.2593).
2
2
4.3.7. Nervosine XIV (7)
2
0
White amorphous powder; [α]
= +20.4 (c 0.450, CHCl ); UV
3
2
2
D
(MeOH) λmax (log ε), 269 (0.29), 246 (0.76) nm; CD (MeOH) λmax(Δε):
248 (+1.51) nm. IR (KBr) νmax 2958, 2923, 2852, 1743, 1711, 1605,
2
−1
1
13
1463, 1377, 1304, 1178, 1092, 962, 863, 770, 721 cm
NMR data, see Table 4; HR-ESI-MS (m/z): 414.2644 [M + H] (calcd
for C25 36NO , 414.2644).
;
H and
C
+
3
2
2
N
H
4
(
10:1:0.2, v/v/v), continually separated over an ODS column with
MeOH-H
2
O (5:95-90:10, v/v) to yield compound 6 (11 mg) and a
4.3.8. Nervosine XV (8)
White amorphous powder; [α]
20
mixture (15.5 mg), which was further isolated by preparative HPLC
with CH CN-H O (3:7, v/v) to afford compound 7 (19 mg). Fr.C was
subjected to neutral Al CC and silica gel CC in succession to yield
three subfractions, Fr.C1–Fr.C3. Fr.C1 was submitted to silica gel CC
and eluted with CH Cl -MeOH (40:1, v/v) to produce compound 5
18 mg). Fr.C2 was subjected to ODS CC and silica gel CC in succession
to yield compound 8 (28 mg).
= +10.4 (c 0.500, MeOH); UV
D
(MeOH) λmax (log ε), 279 (0.56), 206 (1.22) nm; CD (MeOH) λmax(Δε):
217 (−0.46) nm. IR (KBr) νmax 3403, 2973, 2927, 1706, 1655, 1599,
1513, 1451, 1376, 1353, 1283, 1208, 1177, 1061, 1025, 973, 914, 839,
3
2
2 3
O
−
1
1
13
811 cm
;
H and+ C NMR data, see Table 4; HR-ESI-MS (m/z):
2
2
(
6
446.2544 [M + H] (calcd for C25H36NO , 446.2543).
4.4. Acid hydrolysis of 1–3
4
.3.1. Nervosine X (1)
White amorphous powder; [α] = +19.8 (c 0.550, MeOH); UV
2
0
Compound 1 (about 2 mg) was heated in 1 N HCl-dioxane (1:1,
2 ml) at 85 °C for 3 h. The solution was diluted with H O (3 mL), neu-
tralized with 1 N NaOH, and then extracted with CHCl . The H O layer
was evaporated under a stream of nitrogen. The residue was dissolved
in 1-(trimethylsilyl) imidazole (0.1 ml) and pyridine (0.2 ml), and the
solution was stirred at 60 °C for 20 min. After drying, the residue was
D
(
2
1
MeOH) λmax (log ε), 244 (0.37), 208 (0.84) nm; IR (KBr) νmax 3369,
2
958, 2920, 2879, 2851, 1716, 1631, 1600, 1455, 1384, 1350, 1317,
220, 1182, 1077, 1042, 899, 772, 634 cm
3
2
−1
1
13
.
H and C NMR data,
+
see Table 1; HR-ESI-MS (m/z): 722.3754 [M + H] (calcd for
C H56NO13, 722.3752).
37
2 3 3
partitioned between H O and CHCl . The CHCl layer was analyzed by
GC using a L-CP-Chirasil-Val column (0.32 mm × 25 m). D-glucose was
confirmed by comparison with the retention time of the authentic
standards at 7.65 min. The same analysis was carried out on compounds
2–3 (Huang et al., 2013a).
4
.3.2. Nervosine XI (2)
White amorphous powder; [α] = −1.47 (c 0.950, MeOH); UV
2
0
D
(
2
1
MeOH) λmax (log ε), 244 (0.31), 208 (0.80) nm; IR (KBr) νmax 3389,
966, 2924, 2879, 2072, 1720, 1629, 1602, 1456, 1384, 1284, 1243,
181, 1072, 1039, 901, 757, 637 cm
−1
1
13
;
H and C NMR data, see
+
Table 1; HR-ESI-MS (m/z): 764.3849 [M + H] (calcd for C39
H
58NO14
,
4.5. Alkaline hydrolysis of 1
764.3857).
A solution of compound 1 (8 mg) in 0.5 mL of MeOH was refluxed
with 1 mol/L NaOH (0.5 mL) for 1 h. The reaction mixture was acidified
4
.3.3. Nervosine XII (3)
White amorphous powder; [α] = +1.0 (c 0.300, MeOH); UV
2
0
with 1 mol/L HCl and extracted with CHCl
solution was made alkaline with 1 mol/L NaOH and extracted with
CHCl (3 × 4 mL), evaporation of the organic phase yielded lindelofi-
3
(3 × 4 mL). The aqueous
D
(
2
1
MeOH) λmax (log ε), 240 (0.86), 202 (0.68) nm; IR (KBr) νmax 3370,
964, 2922, 2852, 1716, 1677, 1631, 1600, 1455, 1425, 1383, 1322,
3
−
1 1
275, 1201, 1183, 1132, 1072, 902, 836, 800, 770, 721, 638 cm ; H
dine (3.8 mg) (Huang et al., 2013a). The process was repeated for
compounds 2, 3, and 6–8 (about 2 mg). 1-hydroxymethylpyrrolizidine
and C NMR data, see Table 2; HR-ESI-MS (m/z): 738.3707 [M + H]+
1
3
(
calcd for C37
H56NO14, 738.3701).
3
was analyzed by TLC using CHCl :MeOH:diethylamine = 7:3:0.1 as
developing solvent and iodine for detection, 1–3 and 6–8 gave linde-
lofidine (Rf 0.15) (Fig. S96). UPLC-HR-ESI-MS analysis was carried out
on Waters ACQUITY UPLC/Xevo G2 QTOF mass spectrometer, flow
rate: 0.3 ml/min, at 40 °C, eluent with CH OH/H O (2:8), its retention
3 2
time was at 1.02 min (Fig. S90–Fig. S95).
4
.3.4. Nervosine VII N-oxide (4)
White amorphous powder; [α] = +18.2 (c 0.550, MeOH); UV
2
0
D
(
2
1
MeOH) λmax (log ε), 264 (1.63), 216 (2.22) nm; IR (KBr) νmax 3380,
968, 2915, 2861, 1709, 1631, 1602, 1452, 1376, 1350, 1317, 1285,
246, 1099, 983, 934, 906, 769, 628, 592 cm ; H and C NMR data,
−1
1
13
+
see Table 3; HR-ESI-MS (m/z): 414.2638 [M + H] (calcd for
36NO , 414.2644).
4.6. Cell culture
C
25
H
4
HCT 116 human colon cancer cell line was obtained from ATCC.
These cells were maintained at subconfluence in a 95% air and 5% CO
2
humidified atmosphere at 37 °C. RPMI medium supplemented with 10%
fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin
was used for routine subculturing.
4
.3.5. Chloride-(N-chloromethyl nervosine VII) (5)
20
White amorphous powder; [α] = −59.8 (c 0.400, MeOH); UV
D
(
2
1
MeOH) λmax (log ε), 264 (0.63), 215 (1.19) nm; IR (KBr) νmax 3365,
969, 2926, 2877, 2858, 1711, 1631, 1604, 1464, 1382, 1351, 1313,
−1
1
13
284, 1243, 1184, 1098, 1007, 985, 769 cm ; H and C NMR data,
+
see Table 3; HR-ESI-MS (m/z): 446.2468 [M]
C H37ClNO , 446.2462), 448.2448 [M+2] .
25 3
(calcd for
4.7. Cytotoxicity assay
+
+
The cytotoxicity of the compounds against HCT116 human colon
cell lines was evaluated by the MTT method as described in our pre-
vious paper (Huang et al., 2013a). Cells treated with DMSO (0.1% v/v)
were used as negative controls, whereas adriamycin (≥98%; Sigma
4
.3.6. Nervosine XIII (6)
White amorphous powder; [α] = −4.3 (c 1.400, MeOH); UV
2
0
D
(
MeOH) λmax (log ε), 265 (0.69), 208 (1.48) nm; CD (MeOH) λmax(Δε):
154